A heat-shocked melanoma cell lysate vaccine enhances tumor infiltration by prototypic effector T cells inhibiting tumor growth

BACKGROUND: Immune checkpoint blocker (ICB) therapy has shown survival benefits for some patients with cancer. Nevertheless, many individuals remain refractory or acquire resistance to treatment, motivating the exploration of complementary immunotherapies. Accordingly, cancer vaccines offer an attra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Gleisner, María Alejandra, Pereda, Cristián, Tittarelli, Andrés, Navarrete, Mariela, Fuentes, Camila, Ávalos, Ignacio, Tempio, Fabian, Araya, Juan Pablo, Becker, María Inés, González, Fermín Eduardo, López, Mercedes Natalia, Salazar-Onfray, Flavio
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2020
Matèries:
Oncolytic and Local Immunotherapy
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373330/
https://ncbi.nlm.nih.gov/pubmed/32690772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-000999
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars